Can stem cell molecules rebuild wasted muscles? new trial aims to find out

NCT ID NCT05211986

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tests a new drug called IMM01-STEM, made from stem cell secretions, in 28 people with muscle wasting due to knee osteoarthritis. The main goal is to check safety and find the right dose. Participants receive injections and are monitored for side effects over several weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
IMM01-STEM (a mixture of regenerative molecules from stem cells)
What this could lead to
If it works, this could point toward a new way to rebuild muscle in people with knee osteoarthritis, potentially improving strength and mobility.
What could go wrong
This is an early, small study (28 people) focused on safety, not effectiveness. The treatment may cause side effects or fail to show benefit. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Orthopaedic Specialty Institute

    RECRUITING

    Irvine, California, 92618, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California, Irvine - Alpha Stem Cell Clinic

    ACTIVE_NOT_RECRUITING

    Orange, California, 92868, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.